ABBV's Q4 outlook hinges on surging Skyrizi and Rinvoq demand, as investors watch immunology sales to offset Humira's past ...

Children and adults with Prader-Willi syndrome who previously received once-daily diazoxide choline extended-release tablets ...

Pharmas will need to provide their latest stance on the Most Favored Nation drug pricing plans, while biotech finally gets a ...

Aquestive Therapeutics (NASDAQ:AQST) saw its shares plunge about 40% on Friday after the company said the U.S. Food and Drug ...

Qure N.V. (NASDAQ:QURE) surged around 15% in early trading on Friday after the company said it has secured a Type A meeting ...

Each week, our team shares the latest recall alerts from sources such as the U.S. Food & Drug Administration (FDA), the U.S.

Given the FDA’s decision to initiate the removal of boxed warning labels from hormone therapy products, it may be prescribed ...

LUND, Sweden, Jan. 9, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of the New ...

Marks a world-first as Regentis uses MOCART, a quantitative standard to measure regeneration of cartilage in a clinical ...

Crofelemer has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) and the European Medicines ...

Silicone’s composition gives it a synthetic polymer structure with a silicon-oxygen backbone, making it more resistant to ...

A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...